View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
May 6, 2022

How is fintech innovation progressing in the clinical trial operations industry?

Analysis of patent filings revealse the top companies for fintech related applications in the industry over the past year

By Data Journalism Team

Research and innovation in fintech in the clinical trial operations sector has stagnated in the last quarter.

The most recent figures show that the number of fintech related patent applications in the industry stood at nine in the three months ending March – the same as nine over the same period in 2021.

Figures for patent grants related to fintech followed a different pattern to filings – shrinking from six in the three months ending March 2021 to two in the same period in 2022.

The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.

Fintech is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.

The figures also provide an insight into the largest innovators in the sector.

Johnson & Johnson was the top fintech innovator in the clinical trial operations sector in the latest quarter. The company, which has its headquarters in the United States, filed six fintech related patents in the three months ending March. That was up from two over the same period in 2021.

It was followed by the United States based BridgeBio Pharma Inc with one fintech patent application, South Korea based Hanmi Science Co Ltd (1 application), and the United States based Pfizer Inc (1 application).

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU